Makpime T 500mg/62.5mg Injection
Marketer
Makcur Laboratories Ltd.
Salt Composition
Cefepime (500mg) + Tazobactum (62.5mg)
Overview Makpime T 500mg/62.5mg Injection
Combiflox 500mg/62.5mg Injection, a dual-antibiotic formulation, combats diverse bacterial infections by inhibiting microbial proliferation. Administration must be overseen by a qualified medical practitioner. Consistent adherence to the prescribed dosage schedule is crucial; complete the entire course even with symptom improvement. Typical side effects include nausea, vomiting, diarrhea, and skin rashes. Localized injection site reactions (redness, swelling, pain) may occur but typically subside. Severe or persistent side effects warrant immediate medical attention. Allergic reactions (rash, itching, swelling, dyspnea) require prompt emergency care. Inform your physician about all current medications before commencing treatment. Pregnant or lactating individuals should seek medical counsel prior to use. Alcohol consumption should be avoided due to potential additive drowsiness. While typically non-impairing, driving should be avoided if drowsiness or dizziness occurs.
Primary Ingredients of Makpime T 500mg/62.5mg Injection
No text provided. Please provide the text you would like me to rephrase.
Uses of Makpime T 500mg/62.5mg Injection
Infections caused by bacteria
Major Benefits of Makpime T 500mg/62.5mg Injection:
This medication will be administered by your healthcare provider; please do not attempt self-medication.
Common Side effects of Makpime T 500mg/62.5mg Injection:
- Diarrhea
- Increased white blood cell count (eosinophils)
- Injection site phlebitis
- Skin rash
- Increased liver enzymes
- Positive Coombs test
How to use Makpime T 500mg/62.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Makpime T 500mg/62.5mg Injection works:
Makpime T Injection, containing 500mg of cefepime and 62.5mg of tazobactam, utilizes a dual-drug approach to combat bacterial infections. Cefepime, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Tazobactam, a beta-lactamase inhibitor, counteracts bacterial enzymes that would otherwise neutralize cefepime's effects. This combination improves cefepime's efficacy by overcoming bacterial resistance mechanisms.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Makpime T 500mg/62.5mg Injection concurrently with alcohol. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The injectable medication Makpime T 500mg/62.5mg is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human studies remain scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Makpime T (500mg/62.5mg) is considered safe for breastfeeding mothers. Research in humans indicates minimal drug transfer to breast milk, posing no appreciable risk to the infant.
DrivingUNSAFE
Following administration of Makpime T 500mg/62.5mg Injection, temporary blurred vision may occur. Refrain from driving until visual acuity returns to normal.
KidneyCAUTION
Caution is advised when administering Makpime T 500mg/62.5mg Injection to individuals with impaired renal function. Dosage modification may be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Makpime T 500mg/62.5mg Injection in individuals with hepatic impairment appears to pose minimal risk. Existing evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Makpime T 500mg/62.5mg Injection :
Should you forget a scheduled dose of Makpime T 500mg/62.5mg Injection, seek advice from your physician.
Facts to Know About Makpime T 500mg/62.5mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently